Pfizer Aktie

26,11 EUR +0,10 EUR +0,38 %

10.01.2025

STU

26,75 USD +0,05 USD +0,19 %

nachbörslich11.01.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.147,84 Mrd. EUR

KGV76,67Div. Rendite5,73%

WKN852009

ISINUS7170811035

SymbolPFE

Pfizer Aktien News

Sortieren:Datum Meistgelesen

24.03.22BusinesswirePfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults

23.03.22BusinesswirePfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients

22.03.22BusinesswirePfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts

22.03.22BusinesswirePfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries

17.03.22RSSAdditional definitive proxy soliciting materials and Rule 14(a)(12) material

17.03.22RSSForm DEF 14A 78003

17.03.22RSSForm 4 78003

14.03.22PR NewswireIDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreements for Evaluation of Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma and Additional cMET-Driven Tumors

11.03.22BusinesswirePfizer Completes Acquisition of Arena Pharmaceuticals

09.03.22BusinesswirePfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants

08.03.22BusinesswirePfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

01.03.22BusinesswirePhase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints

28.02.22BusinesswirePfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

25.02.22PR NewswireBiohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment

25.02.22RSSForm 4 78003

24.02.22RSSForm 10-K 78003

22.02.22BusinesswirePfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference

17.02.22RSSForm 4 78003

15.02.22BusinesswirePfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency

15.02.22BusinesswireEuropean Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults

14.02.22PR NewswireBiohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea

11.02.22BusinesswirePfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age

11.02.22RSSForm SC 13G/A 78003

09.02.22BusinesswirePfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

01.02.22BusinesswirePfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA

01.02.22BusinesswirePfizer Announces New Chief Development Officer

31.01.22PR NewswirePfizer and Ionis announce discontinuation of vupanorsen clinical development program

28.01.22BusinesswireEuropean Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer

27.01.22BusinesswirePfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment

25.01.22Businesswire Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age

21.01.22BusinesswirePfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency

14.01.22BusinesswireU.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis

12.01.22BusinesswirePositive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released

Pfizer News

Pfizer News: auf dieser Seite finden Sie alle Pfizer News und Nachrichten zur Pfizer Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pfizer News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pfizer News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.